Fountainhead AM’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
2,112
-29
| -1% | -$5.38K | 0.06% | 133 |
|
|
2025
Q1 | $449K | Buy |
2,141
+359
| +20% | +$75.2K | 0.07% | 101 |
|
|
2024
Q4 | $317K | Buy |
1,782
+330
| +23% | +$58.6K | 0.06% | 118 |
|
|
2024
Q3 | $287K | Sell |
1,452
-65
| -4% | -$12.8K | 0.06% | 112 |
|
|
2024
Q2 | $260K | Sell |
1,517
-104
| -6% | -$17.8K | 0.06% | 106 |
|
|
2024
Q1 | $295K | Buy |
1,621
+13
| +0.8% | +$2.37K | 0.07% | 94 |
|
|
2023
Q4 | $249K | Buy |
1,608
+17
| +1% | +$2.64K | 0.07% | 95 |
|
|
2023
Q3 | $237K | Buy |
+1,591
| New | +$237K | 0.08% | 77 |
|
|
2023
Q2 | – | Sell |
-1,475
| Closed | -$235K | – | 84 |
|
|
2023
Q1 | $235K | Sell |
1,475
-39
| -3% | -$6.22K | 0.09% | 65 |
|
|
2022
Q4 | $245K | Buy |
+1,514
| New | +$245K | 0.11% | 56 |
|
|
2022
Q3 | – | Sell |
-1,308
| Closed | -$200K | – | 77 |
|
|
2022
Q2 | $200K | Buy |
1,308
+12
| +0.9% | +$1.84K | 0.11% | 65 |
|
|
2022
Q1 | $210K | Buy |
+1,296
| New | +$210K | 0.09% | 69 |
|